Cardiff Oncology (CRDF) Revenue & Revenue Breakdown
Cardiff Oncology Revenue Highlights
Latest Revenue (Y)
$488.00K
Latest Revenue (Q)
$165.00K
Main Segment (Y)
Royalty
Main Geography (Y)
Royalty
Cardiff Oncology Revenue by Period
Cardiff Oncology Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $488.00K | 26.42% |
| 2022-12-31 | $386.00K | 7.52% |
| 2021-12-31 | $359.00K | -1.91% |
| 2020-12-31 | $365.99K | 49.38% |
| 2019-12-31 | $245.00K | -35.19% |
| 2018-12-31 | $378.00K | -25.15% |
| 2017-12-31 | $505.00K | 32.55% |
| 2016-12-31 | $381.00K | 21.73% |
| 2015-12-31 | $313.00K | 11.79% |
| 2014-12-31 | $280.00K | 8.01% |
| 2013-12-31 | $259.25K | -42.39% |
| 2012-12-31 | $450.00K | 74.62% |
| 2011-12-31 | $257.70K | -3.00% |
| 2010-12-31 | $265.67K | -59.13% |
| 2009-12-31 | $650.00K | 100.00% |
| 2006-01-31 | - | 100.00% |
| 2005-01-31 | - | - |
Cardiff Oncology generated $488.00K in revenue during NA 2023, up 26.42% compared to the previous quarter, and up 129.10% compared to the same period a year ago.
Cardiff Oncology Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $165.00K | 1.23% |
| 2024-06-30 | $163.00K | -20.49% |
| 2024-03-31 | $205.00K | 31.41% |
| 2023-12-31 | $156.00K | 10.64% |
| 2023-09-30 | $141.00K | 30.56% |
| 2023-06-30 | $108.00K | 30.12% |
| 2023-03-31 | $83.00K | -35.16% |
| 2022-12-31 | $128.00K | 37.63% |
| 2022-09-30 | $93.00K | 2.20% |
| 2022-06-30 | $91.00K | 22.97% |
| 2022-03-31 | $74.00K | -44.36% |
| 2021-12-31 | $133.00K | 54.65% |
| 2021-09-30 | $86.00K | 26.47% |
| 2021-06-30 | $68.00K | -5.56% |
| 2021-03-31 | $72.00K | -39.63% |
| 2020-12-31 | $119.25K | -12.57% |
| 2020-09-30 | $136.40K | 219.94% |
| 2020-06-30 | $42.63K | -37.03% |
| 2020-03-31 | $67.70K | -27.20% |
| 2019-12-31 | $93.00K | 79.93% |
| 2019-09-30 | $51.69K | -62.55% |
| 2019-06-30 | $138.00K | -14.81% |
| 2019-03-31 | $162.00K | 107.69% |
| 2018-12-31 | $78.00K | -11.73% |
| 2018-09-30 | $88.36K | -20.97% |
| 2018-06-30 | $111.81K | 11.66% |
| 2018-03-31 | $100.14K | -45.87% |
| 2017-12-31 | $185.00K | 50.01% |
| 2017-09-30 | $123.33K | 20.90% |
| 2017-06-30 | $102.01K | 7.34% |
| 2017-03-31 | $95.04K | 39.76% |
| 2016-12-31 | $68.00K | -23.69% |
| 2016-09-30 | $89.11K | -13.82% |
| 2016-06-30 | $103.40K | -14.18% |
| 2016-03-31 | $120.49K | 52.19% |
| 2015-12-31 | $79.17K | 38.10% |
| 2015-09-30 | $57.33K | 16.17% |
| 2015-06-30 | $49.35K | -61.14% |
| 2015-03-31 | $126.97K | 125.13% |
| 2014-12-31 | $56.40K | -1.40% |
| 2014-09-30 | $57.20K | 2.82% |
| 2014-06-30 | $55.63K | -49.86% |
| 2014-03-31 | $110.95K | 134.24% |
| 2013-12-31 | $47.37K | 8.25% |
| 2013-09-30 | $43.76K | -10.70% |
| 2013-06-30 | $49.00K | -58.87% |
| 2013-03-31 | $119.12K | -27.03% |
| 2012-12-31 | $163.25K | -22.81% |
| 2012-09-30 | $211.50K | 409.64% |
| 2012-06-30 | $41.50K | 21.51% |
| 2012-03-31 | $34.15K | 1.19% |
| 2011-12-31 | $33.75K | -38.64% |
| 2011-09-30 | $55.00K | -31.13% |
| 2011-06-30 | $79.86K | -10.35% |
| 2011-03-31 | $89.08K | -57.58% |
| 2010-12-31 | $210.00K | 600.00% |
| 2010-09-30 | $30.00K | 50.00% |
| 2010-06-30 | $20.00K | 100.00% |
| 2010-03-31 | - | - |
Cardiff Oncology generated $165.00K in revenue during Q3 2024, up 1.23% compared to the previous quarter, and up 152.78% compared to the same period a year ago.
Cardiff Oncology Revenue Breakdown
Cardiff Oncology Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 20 | Dec 19 |
|---|---|---|
| Royalty | $365.99K | $243.14K |
| Service | - | $1.50K |
Cardiff Oncology's latest annual revenue breakdown by segment (product or service), as of Dec 20: Royalty (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|
| Royalty | $92.58K | $51.69K | $36.85K |
| Service | - | - | $101.43K |
Cardiff Oncology's latest quarterly revenue breakdown by segment (product or service), as of Dec 19: Royalty (100.00%).
Cardiff Oncology Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 | Dec 19 |
|---|---|---|
| Royalty | $365.99K | $243.14K |
| Service | - | $1.50K |
Cardiff Oncology's latest annual revenue breakdown by geography, as of Dec 20: Royalty (100.00%).
Quarterly Revenue by Country
| Country | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|
| Royalty | $92.58K | $51.69K | $36.85K |
| Service | - | - | $101.43K |
Cardiff Oncology's latest quarterly revenue breakdown by geography, as of Dec 19: Royalty (100.00%).
Cardiff Oncology Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MREO | Mereo BioPharma Group | $10.00M | - |
| BOLT | Bolt Biotherapeutics | $7.88M | $1.14M |
| CUE | Cue Biopharma | $5.49M | $3.34M |
| AUTL | Autolus Therapeutics | $1.70M | - |
| LYRA | Lyra Therapeutics | $1.56M | $195.00K |
| CRDF | Cardiff Oncology | $488.00K | $165.00K |
| EYEN | Eyenovia | $3.79K | $1.63K |
| NLSP | NLS Pharmaceutics | - | - |
| CGEM | Cullinan Oncology | - | - |
| GRCL | Gracell Bio | - | - |
| RVPH | Reviva Pharmaceuticals | - | - |
| PDSB | PDS Bio | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| INAB | IN8bio | - | - |
| CGTX | Cognition Therapeutics | - | - |
| KOD | Kodiak Sciences | - | - |
| LTRN | Lantern Pharma | - | - |
| SLS | SELLAS Life Sciences Group | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |